Zobrazeno 1 - 6
of 6
pro vyhledávání: '"María Belén Marzal-Alfaro"'
Autor:
Cristina Villanueva-Bueno, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, José Luis Revuelta-Herrero, María Belén Marzal-Alfaro, Eva González-Haba, José Ángel Arranz-Arija, Santiago Osorio, Ana Herranz-Alonso, María Sanjurjo-Saez
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
ObjectiveThis study aims to analyze the impact of the eOncosalud app on the management and follow-up of adverse effects (AE) in patients receiving oral antineoplastic agents.Material and methodsWe performed an observational, prospective study of canc
Externí odkaz:
https://doaj.org/article/f07822eba5894259b777035de08df288
Autor:
Sebastián García-Sánchez, Roberto Collado-Borrell, Eva González-Haba, José Luis Revuelta-Herrero, Vicente Escudero-Vilaplana, María Belén Marzal-Alfaro, María Norberta Sánchez-Fresneda, Ana Mur-Mur, Ana Herranz, Miguel Martín, María Sanjurjo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundOncology clinical trials can lead to relevant financial savings in drug acquisition for healthcare providers. Considerable methodological heterogeneity is observed among previous studies estimating these savings.MethodsWe developed a method
Externí odkaz:
https://doaj.org/article/ef21ba18017e49daaff1a9ba9314cef3
Autor:
Vicente Escudero-Vilaplana, Antonio Calles, Roberto Collado-Borrell, María Belén Marzal-Alfaro, Carlos Polanco, Carmen Garrido, Jorge Suarez, Aurora Ortiz, Marilena Appierto, Marta Comellas, Luis Lizán
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: Lung cancer (LC) and its treatment impose a significant burden on patients' life. However, patient-centered outcomes are rarely collected during patient follow-up. Filling this gap, the International Consortium for Health Outcomes Measuremen
Externí odkaz:
https://doaj.org/article/dd1f2e5a1aa94c6a994357f955246977
Autor:
JL Revuelta Herrero, E González Haba-Peña, A De Lorenzo-Pinto, MN Sanchez-Fresneda, Raquel García-Sánchez, Vicente Escudero-Vilaplana, Ana Herranz-Alonso, Roberto Collado-Borrell, María Sanjurjo-Sáez, María Belén Marzal-Alfaro
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background To our knowledge, there is no pharmacy stratification model for patients in the oncology ambulatory setting. Purpose To develop a tool to stratify oncology patients that helps us to implement ambulatory clinical pharmacy services. Material
Autor:
María Luisa Martín Barbero, María Luisa Martínez Ginés, JoseM García Domínguez, María Belén Marzal-Alfaro, Fernando Romero-Delgado, Ana Herranz, María Sanjurjo-Sáez
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
OBJECTIVES: To assess the effectiveness and tolerability of fampridine in patients with multiple sclerosis (MS) in real clinical practice and to analyse adherence to treatment and general satisfaction of patients in terms of quality of life (QOL). ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70867a1b1cc28afb9517986d600ecd8e
https://hdl.handle.net/20.500.12530/34205
https://hdl.handle.net/20.500.12530/34205
Autor:
María Belen Marzal-Alfaro, Vicente Escudero-Vilaplana, Jose Luis Revuelta-Herrero, Roberto Collado-Borrell, Ana Herranz-Alonso, Maria Sanjurjo-Saez
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeThe use process for chimeric antigen receptor T (CAR-T) cell drugs is complex and has been associated with a number of potentially severe complications, which requires management by a multidisciplinary team. Pharmacists are a key element in th
Externí odkaz:
https://doaj.org/article/e5a63c2b25e74892b585ad18dcfff5dd